The lab uses PCR technology to detect pathogens and resistance genes .The results are transmitted to the PharmD system via interface, which standardizes data exchange.
A trained pharmacist carefully reviews the detected pathogens and resistance genes, providing a report with evidence-based treatment recommendations.
The completed PharmD report is transmitted back to the Laboratory Information System. It is then merged with the laboratory report for easy access.
The healthcare provider reviews both the lab results and the PharmD report to select the most appropriate drug therapy for the patient based on the evidence presented.
This process ensures that healthcare providers receive accurate, up-to-date information to make informed decisions about patient treatment.
Value-based programs reward health care providers with incentive payments for the quality of care they give to people with Medicare. These programs are part of our larger quality strategy to reform how healthcare is delivered and paid for. Value-based programs also support our three-part aim:
Our value-based programs are important because they’re helping us move toward paying providers based on the quality, rather than the quantity of care they give patients.
© 2021 RXCarePath. All rights reserved
Design And Developed By ADMSoft